Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FWZSW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,613
Award facts
- Contract value 100% obligated
- $17,613.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units, with a contract ceiling value of $17,613.10. This competitively awarded, non-set-aside delivery order reflects a firm fixed-price arrangement with a completion date of September 3, 2025. The order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion master contract running through December 2026 that serves as the pharmaceutical prime vendor vehicle for global military healthcare operations.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, leverages its comprehensive federal contract portfolio to fulfill critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's DLA IDC enables it to supply an extensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for XELJANZ XR—a rheumatoid arthritis treatment—represents routine pharmaceutical fulfillment under the larger vehicle and demonstrates AmerisourceBergen's capacity to meet federal medical procurement requirements through open competitive processes.
Quick answers
Who was awarded contract SPE2DB25FWZSW?
SPE2DB25FWZSW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FWZSW worth?
The government has obligated $17,613 on SPE2DB25FWZSW.
Is contract SPE2DB25FWZSW an order under another contract?
Yes. SPE2DB25FWZSW is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FWZSW competed?
The extent of competition for SPE2DB25FWZSW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award